{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"event-entities","count":2,"summary":{"policyEntityCount":21,"relationshipCount":31,"officialEventCount":14,"linkedEventCount":12,"unlinkedEventCount":2,"marketCount":7,"sourceCount":11,"agencyCount":4,"profileCrosswalkCount":6,"firstYear":2019,"latestYear":2026,"spanLabel":"2019-2026"},"guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","policyEntityFilters":{"policyEntity":"optumrx-inc","policyEntityMatched":true,"entityId":"pent-optumrx","slug":"optumrx-inc","name":"OptumRx, Inc.","role":null,"roleMatched":null},"rows":[{"id":"peel-optumrx-complaint","eventId":"evt-pbm-insulin-complaint-2024","eventDate":"2024-09-20","eventTitle":"FTC files administrative complaint against the three largest PBMs","eventStage":"litigation","eventType":"complaint","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-optumrx","entitySlug":"optumrx-inc","entityName":"OptumRx, Inc.","role":"respondent","roleLabel":"Respondent","evidenceSummary":"The FTC administrative complaint names OptumRx as a respondent.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-insulin-complaint-2024","sourceTitle":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","sourceAccessDate":"2026-07-17","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/optumrx-inc","recordProfileHref":"/enforcement/records/pbm-insulin-complaint-2024","enforcementHref":"/enforcement?policyEntity=optumrx-inc&enforcementEvent=evt-pbm-insulin-complaint-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-insulin-complaint-2024"},{"id":"peel-optumrx-report","eventId":"evt-pbm-interim-report-2024","eventDate":"2024-07-09","eventTitle":"FTC releases interim staff report on prescription drug middlemen","eventStage":"monitoring","eventType":"report","agency":"Federal Trade Commission","docketNumber":null,"entityId":"pent-optumrx","entitySlug":"optumrx-inc","entityName":"OptumRx, Inc.","role":"report_subject","roleLabel":"Report subject","evidenceSummary":"The FTC interim report identifies OptumRx among the six PBMs that received Section 6(b) orders.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","sourceAccessDate":"2026-05-16","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/optumrx-inc","recordProfileHref":"/enforcement/records/pbm-interim-report-2024","enforcementHref":"/enforcement?policyEntity=optumrx-inc&enforcementEvent=evt-pbm-interim-report-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-interim-2024"}]}